Pfizer, Inc. (PFE) Tops Q4 EPS by 3c; Cuts FY12 Outlook
PFE Hot Sheet
EPS Growth %: -3.3%Financial Fact:
Net income attributable to Pfizer Inc.: 1.79B
Today's EPS Names:
TARO, BRLI, TLB, More
Pfizer, Inc. (NYSE: PFE) reported Q4 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $16.7 billion versus the consensus estimate of $16.61 billion.
Lowered its FY12 non-GAAP EPS guidance from $2.25-$2.35 to $2.20-$2.30, which compares to the Street estimate of $2.30.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Lowered its FY12 non-GAAP EPS guidance from $2.25-$2.35 to $2.20-$2.30, which compares to the Street estimate of $2.30.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
